Rousseau Gama

Rousseau Gama is a Professor of Laboratory and Metabolic Medicine at the University of Wolverhampton, with a secondary role as Consultant Chemical Pathologist at Black Country Pathology Services (Royal Wolverhampton NHS Trust). He holds formal affiliations with the Faculty of Science and Engineering and School of Medicine and Clinical Practice. His work bridges clinical practice, academic research, and education.

• Education
  • BSc in Biochemistry (University of Liverpool)
  • MB ChB (University of Liverpool)
  • MSc in Clinical Biochemistry (University of Surrey)
  • MRCP, MD (Chemical Pathology), MRCPath, FRCP, FRCPath, and CChem FRSC

His research interests focus on laboratory healthcare delivery to improve patient safety, care, and outcomes. This includes:

• Developing clinical pathways for metabolic disorders
• Addressing sample contamination (EDTA, citrate) in diagnostics
• Standardization of endocrine and metabolic assays

Recent publication trends highlight his expertise in:

• Metabolic biomarker validation
• Diagnostic interference mechanisms
• Endocrine testing variability
• Clinical pathway optimization

Scientific recognition includes:

• Fellowships: FRCP (Royal College of Physicians), FRCPath (Royal College of Pathologists), CChem FRSC (Royal Society of Chemistry)

His teaching activities span:

• Undergraduate/postgraduate Biomedical Science curriculum
• Examiner roles for Royal College of Pathologists (2008–2019)
• Academic leadership in clinical biochemistry training programs

He served as chief investigator on grants like Fecal biomarkers in pregnancy and IBD (2015–2019), which funded researchers including Dr. M. Brookes.